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Bacterial persistence represents a simple of phenotypic heterogeneity,
whereby a proportion of cells in an isogenic bacterial population can survive
exposure to lethal stresses such as antibiotics. In contrast, genetically based
antibiotic resistance allows for continued growth in the presence of antibi-
otics. It is unclear, however, whether resistance and persistence are comple-
mentary or alternative evolutionary adaptations to antibiotics. Here, we
investigate the co-evolution of resistance and persistence across the genus
Pseudomonas using comparative methods that correct for phylogenetic nonin-
dependence. We find that strains of Pseudomonas vary extensively in both
their intrinsic resistance to antibiotics (ciprofloxacin and rifampicin) and
persistence following exposure to these antibiotics. Crucially, we find that
persistence correlates positively to antibiotic resistance across strains. How-
ever, we find that different genes control resistance and persistence implying
that they are independent traits. Specifically, we find that the number of
type II toxin–antitoxin systems (TAs) in the genome of a strain is correlated
to persistence, but not resistance. Our study shows that persistence and
antibiotic resistance are complementary, but independent, evolutionary
adaptations to stress and it highlights the key role played by TAs in the evo-
lution of persistence.
Introduction
It is often assumed that populations of isogenic bacteria
are phenotypically and physiologically identical. How-
ever, even under laboratory conditions specifically
designed to generate homogeneous conditions, bacteria
almost always show considerable phenotypic variation
within a population (Dubnau & Losick, 2006; Grau-
mann, 2006; Veening et al., 2008; Lidstrom & Konopka,
2010). For example, a small fraction of cells in clonal
bacterial populations are phenotypically resistant to
sudden exposure to stress, a phenomenon that has
been termed ‘persistence’. Although first described in
the 1940s (Hobby et al., 1942; Bigger, 1944a, b), the
interest in bacterial persistence has increased in the last
15 years (Lewis, 2007; Allison et al., 2011; Balaban,
2011; Fauvart et al., 2011). This is because persistence
protects bacteria against a number of clinically relevant
stressors including high doses of antibiotics, but also
phagocytosis by macrophages (Ramage et al., 2009;
Helaine et al., 2014), and consequently, persistence is
thought to contribute to many chronic and recurrent
infections (Lewis, 2007, 2008; Allison et al., 2011; Bala-
ban, 2011). Whether or not persister cells are dormant
remains an ongoing discussion (Balaban et al., 2013;
Wood et al., 2013), but mechanistically persisters repre-
sent a subset of cells recalcitrant to sudden stress.
Although persisters are known to be induced by certain
stimuli, many persister cells are formed prior to the
onset of any stress as a result of stochastic processes
operating at a cellular level (Balaban et al., 2004). Per-
sisters therefore represent a form of evolutionary bet-
hedging (Slatkin, 1974; Philippi & Seger, 1989);
although most cells of a given genotype will grow in
favourable conditions, a subset of cells differentiate into
a stress tolerant state to insure against sudden environ-
mental change.
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Persistence is an example of phenotypic plasticity,
and represents one evolutionary strategy for coping
with stressful environments, and is often referred to as
antibiotic tolerance (Lewis, 2008; Kint et al., 2012; Frid-
man et al., 2014). Alternatively, bacterial populations
can adapt to stress by evolving more conventional non-
plastic adaptations which allow continued population
growth in the presence of the stress, which in the con-
text of antibiotics is referred to as resistance. Genetically
elevated levels of resistance typically evolve by chromo-
somal mutations that modify the targets of antibiotics
or by acquiring mobile elements carrying genes that
chemically modify or degrade antibiotics (reviewed in
Blair et al., 2015). Whereas persistence allows a small
fraction of a bacterial population to escape from stress
in a nonreplicative state, genetic resistance allows bac-
teria to continue to reproduce under stressful condi-
tions. Very broadly, theory predicts that the constancy
of exposure to stress is crucial in determining whether
selection favours the evolution of tolerance or resis-
tance (Kussell et al., 2005). If a selection pressure is
constant, there is no advantage to a plastic trait such as
tolerance. Indeed, in the case of persistence, increased
levels could not evolve in response to continuous expo-
sure to stress as cells exiting from a persistent to a
replicative state would be killed by the stressor. In con-
trast, intermittent selection could favour either elevated
persistence or resistance.
As some environments can favour the evolution of
either resistance or tolerance, whether persistence and
antibiotic resistance represent complementary or alter-
native adaptations is unclear. Intuitively, a population
which has evolved a high level of antibiotic resistance
will experience less selection for high-level persistence,
as persistence is not required to survive novel stresses.
Similarly, in a population with high-level persistence, a
resistant mutant will have a smaller selective benefit.
Conversely, as both are fundamentally adaptations to
the same environmental stress, both may evolve in
response to the same selection pressure. Empirical sup-
port for the relationship between persistence and resis-
tance is mixed. For example, several papers have
shown that there is no association between antibiotic
susceptibility and persistence between clones from the
same species (Stewart & Rozen, 2012; Hofsteenge et al.,
2013), suggesting that resistance and persistence may
be unrelated. However, these studies did not control for
the potentially confounding effects of phylogenetic
nonindependence, so their results should be treated
with caution. In contrast, analysis of bacteria from
chronic infections suggests the two traits may have a
more complicated relationship. The evolution of antibi-
otic resistance during chronic infections is a problem of
significant medical importance (Hogardt & Heesemann,
2013; Smith et al., 2013; Cullen & McClean, 2015).
However, despite repeated exposures to antibiotics, not
all chronic infections evolve antibiotic resistance, which
has sometimes been referred to as the paradox of
chronic infections (Lewis, 2010a, b). Instead, longitudi-
nal analysis of isolates from chronic infections suggests
that some populations evolve persistence but not resis-
tance (LaFleur et al., 2010; Mulcahy et al., 2010). This
suggests that in some circumstances, resistance and per-
sistence may represent alternative adaptations to the
same selection pressure.
Although data on the relationship between resistance
and persistence at a microevolutionary scale are limited,
there is even less evidence at larger evolutionary scales.
Therefore, to further explore the relationship between
persistence and resistance, we tested for a correlation
between the two types of defence strategies from bacte-
ria from different strains of Pseudomonas. We wished to
test whether different strains adopted fundamentally
different strategies with coping with stress and whether
some strains evolve high resistance but low persistence,
whereas some favoured vice versa. If stressful environ-
ments generate selection for both resistance and persis-
tence, then these traits should be positively correlated
across strains. On the other hand, if persistence and
resistance are alternative evolutionary strategies, then a
negative correlation should exist between these traits.
Finally, it is possible that there is no general relation-
ship between persistence and resistance. Phylogenetic
nonindependence can lead to spurious correlations
between traits across strains that are driven by common
ancestry. To account for this problem, we tested for
associations between persistence and resistance using
comparative methods that explicitly account for the
phylogeny of Pseudomonas (Vogwill et al., 2014). Specifi-
cally, trait-association studies can be biased by unequal
phylogenetic relatedness. In other words, traits can
appear associated because closely related strains are
more likely than average to have similar phenotypes,
and thereby obscure any actual relationship between
the traits from differing branches of a phylogeny.
The second aim of this study was to explore the
genetic mechanisms underpinning this variation in per-
sistence. Although the mechanistic basis of persistence
was long seen as highly complicated and elusive, recent
work has shown that type II toxin–antitoxin systems
(TAs) play a central role in persister formation. Type II
TAs encode a toxin protein and corresponding antitoxin
protein (Schuster & Bertram, 2013). The antitoxin neu-
tralizes the toxin, preventing the activity of the toxin
when both are present. The antitoxins in these systems
are either less stress tolerant or have a shorter half-life
than the toxins. Therefore, certain stresses (Maison-
neuve et al., 2013), or simply stochastic gene expression
(Fasani & Savageau, 2013), can result in the toxin
becoming active. Several different lines of evidence
implicate type II TAs in persister formation (Lewis &
Hansen, 2013; Schuster & Bertram, 2013; Holden,
2015). For example, the first mutant isolated with a
higher persister fraction was an Escherichia coli which
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had a mutation in the HIPA toxin gene (Moyed & Ber-
trand, 1983). Moreover, by sequentially knocking out
type II TAs, it has been experimentally demonstrated
the number of TAs in a genome is proportional to the
number of persisters within that population (Maison-
neuve et al., 2011). However, to our knowledge, there
are no comparative tests of this link between type II TA
frequency and persister formation. We therefore used
our experimental data to test the hypothesis that the
number of TAs within a genome would predict the
level of persistence but not resistance. This would allow
us to separate whether the relationship between resis-




The eight strains of Pseudomonas are listed in Fig. 1. Prior
to experimentation, all strains were stored in 20% glyc-
erol at 80 °C. Strains were cultured in liquid King’s B
media (KB), at 30 °C with constant shaking at 250 rpm.
Kill curves
We define persistence as the number of cells surviving
4 h of antibiotic exposure. To assay the level of persis-
tence of our bacterial isolates, we performed survival
curves for each strain of bacteria for two antibiotics. We
use the DNA gyrase inhibitor, ciprofloxacin, and the
RNA polymerase inhibitor, rifampicin. These antibiotics
have different cellular targets and are chemical distinct.
Each bacterial isolate was initially cultured overnight in
liquid King’s B media (KB) at 30 °C with constant shak-
ing at 250 rpm. Samples were then diluted 20-fold into
fresh KB media and recultured for 2 h to standardize all
culture to exponential phase growth. After 2 h, an ali-
quot of this culture was plated to determine its density,
after which the remaining culture had the relevant
antibiotic added to it. After 4 h, another aliquot of this
culture was plated to redetermine its density, and the
level of persistence was calculated as the proportion or
bacteria surviving antibiotic exposure. This assay was
performed for both antibiotics, at the MIC (minimum
inhibitory concentration, see below), 29 and 49MIC for
the strain with highest MIC for that antibiotic. Conve-
niently, this range of doses included 49 the MIC for
seven of the strains to each antibiotic. For the strains
with 49MIC outside this range, we performed additional
kill curves, specifically P. fulva CCUG 12573 to rifampicin
and P. stutzeri ATCC 17588 to ciprofloxacin. Pilot kill
curves were initially performed in which the density of
bacteria was assayed every hour for 6 h post-antibiotic
exposure (Fig. 2). Four hours was found to representa-
tive to the level of persistence regardless of time period
for the antibiotics included here.
Resistance profiles
The resistance profiles for these strains were taken from
a manuscript in preparation by Furio and Maclean.
Briefly, to assay the resistance of our bacterial isolates,
the MICs were determined by EUCAST standard meth-
ods for each of 24 antibiotics. Five to ten morphologi-
cally similar colonies of each strain were suspended in
sterile saline solution (NaCl 0.9%). A sample of this sus-
pension was then used to inoculate approximately 105
cells into each well of a microtitre plate contacting a
two-fold dilution series of a particular antibiotic. The
plate was then incubated for 24 h at 30 °C, after which
the optical density at 595 nm was measured using a Bio-
Tek Synergy 2 microplate reader (Bio-Tek, Winooski,
VT, USA). The lowest antibiotic concentration at which
growth had been completely inhibited was considered
the MIC. This was repeated three times for each antibi-
otic by strain combination. This was performed for a
total of 24 antibiotics: ceftazidime, cefotaxime, ceftriax-
one, meropenem, piperacillin, carbencillin, azteronam,
kanamycin, streptomycin, gentamycin, amikacin,
Fig. 1 Schematic of the study system
showing the phylogenetic relationship
of the strains. The numbers following
each strain’s name represent the
minimum inhibitory concentrations to
rifampicin and ciprofloxacin,
respectively, followed by the strain’s
genome size.
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tobramycin, ciprofloxacin, levofloxacin, feroxacin, col-
istin, polymixin B, sulfamethoxazole, mafenide, chlo-
ramphenicol, rifampicin, fosfomycin, spectinomycin and
tetracycline. All antibiotics were ordered from Sigma,
and stocks were prepared according to the manufac-
turer’s instructions and stored at 20 °C.
The MICs of different antibiotics can vary across sev-
eral magnitudes of scale, rendering a raw mean across
different antibiotics largely meaningless. For example,
some antibiotics are active at ng mL1, whereas others
require mg mL1. Therefore, to provide a general mea-
sure of resistance, we standardize the differing antibi-
otics by first calculating a z-score for each strain to
each antibiotic. A z-score is a dimensionless standard-
ized variable, calculated as the difference between a
variable and its mean, standardized by dividing by the
standard deviation of the mean. For each antibiotic,
MICs were first log-transformed so that they would be
on a linear scale, then all three replicates for each strain–
antibiotic combination were averaged prior to z-scores
being calculated. As some of the antibiotics used are from
the same family, we averaged z-scores for antibiotics of
the same family together. This reduced our 24 scores to
just 10: beta-lactams, aminoglycosides, fluoroquinol
ones, polymyxins, sulphonamides, chloramphenicol,
rifampicin, fosfomycin, spectinomycin and tetracycline.
Finally, we took the average of those 10 z-scores as our
resistance measurement for each strain.
Phylogenetic analysis
Trait-association studies can be biased by unequal phy-
logenetic relatedness. In other words, traits can appear
associated because closely related strains are more likely
than average to have similar phenotypes, and thereby
obscure any actual relationship between the traits from
differing branches of a phylogeny. Here, we control for
this using phylogenetic independent contrasts (PICs)
performed using the method of Felsenstein (Felsenstein,
1985), calculated using the Pseudomonas phylogeny
from Vogwill et al. (2014). In short, this method
compares the change in a trait between neighbouring
nodes or tips and then standardizes for the distance
between these nodes/tips, thereby controlling for some
strains being more closely related than others. When
this is performed for more than one trait, the size or
direction of these contrasts can then be analysed to
look for correlated evolution of different traits. For the
eight strains in this study system, we can calculate
seven contrasts. However, as it is customary to con-
strain the correlation of these traits through the origin,
there is no loss of statistical power.
Bioinformatic analysis of toxin–antitoxin systems
The number of toxin–antitoxin pairs per strain was
downloaded from the Toxin-Antitoxin Database (TADB).
This database provides a confidence score for each TA
loci as a percentage. We use anything predicted to be a
TAs with at least 50% confidence from the TADB. Note
that this value correlates with both anything reported as
a TAs in the TADB, as well as with the number of TAs
reported with 90% confidence.
Statistical analysis
All statistical tests were performed in SPSS 16 (SPSS
Inc., Chicago, IL, USA). Variation in persistence was
analysed using general linear models and associates
between different traits using phylogenetically corrected
correlations. Proportions of variances explained were
calculated using standard methods.
Results
Persistence varies between strains, antibiotic and
doses of antibiotic
Using kill curves, we measured levels of persistence for
eight isolates of Pseudomonas (Fig. 1) to three doses of
Fig. 2 Example of the kill curves used
to assay persistence, for four bacterial
strains at one concentration of an
antibiotic. An initial sample is plated at
0 h, after which antibiotics are
immediately added to each tube.
Subsequent samples are then plated
every hour for 6 h. Cell densities are
expressed relative to the density at 0 h.
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Fig. 3 Persistence varies between strains, antibiotics and doses. Bars represent mean proportion surviving cells ( SE) after 4 h exposure
to either ciprofloxacin (panel a) or rifampicin (panel b). For panel a, black, grey and white bars represent 60, 120 and 240 ng L1,
respectively. For panel b, black, grey and white bars represent 15, 30 and 60 lg L1, respectively.
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the antibiotics ciprofloxacin and rifampicin (Fig. 3). We
find that persistence is significantly affected by both the
bacterial strain (full statistical results in Table 1; strain:
F7,239 = 115.89, P < 0.001) and the dose of the antibi-
otic (dose: F2,239 = 89.68, P < 0.001), but not directly
by the identity antibiotic itself (antibiotic: F1,239 = 1.11,
P = 0.293). Specifically, the strain explained 46.3% of
the variance in persistence, whereas the dose of antibi-
otic explained 10.2% of the variance, demonstrating
that the majority of variation in persistence is between
strains.
As antibiotic dose significantly affected persistence, we
repeated the analysis using just persistence at 49 MIC
for each strain. Bacterial strain was again found to
significantly affect persistence (strain: F7,80 = 13.44,
P < 0.001) and explained 36.6% of the variance. At this
dose, there was statistically significant variation in persis-
tence between antibiotics (antibiotic: F1,80 = 7.48,
P < 0.01), but the strength of this effect was weak,
accounting for only 2.9% of the variance in persistence.
The interaction of strain and antibiotic, on the other
hand, accounted for 28.2% of the variance in persistence
(antibiotic by strain interaction: F7,80 = 10.39,
P < 0.001). As strain is found to be the strongest predic-
tor of persistence, we therefore define persistence for the
rest of this manuscript as the mean antibiotic survival at
four times a strain’s MIC, averaged across both antibi-
otics. However, it should be noted that the results of the
analysis do not change if a mean across all doses is used,
or if persistence at any particular dose is also used.
Persistence and resistance: complimentary or
alternative adaptations
To provide a broad measure of antibiotic susceptibility,
we first measured the MIC for 24 antibiotics for each
strain. We then converted this into a z-score to provide
a relative measure of antibiotic resistance. We find that
mean antibiotic susceptibility does significantly corre-
late with mean persistence at 49 MIC (Fig. 4a;
r = 0.787, d.f. = 6, P < 0.05). This is also true if we
limit the measure of antibiotic resistance to just the
mean of the two antibiotics used to assay persistence
(r = 0.769, d.f. = 6, P < 0.05), or if we treat the two
antibiotics as independent measures of resistance and
persistence (r = 0.594, d.f. = 14, P < 0.05). However,
this analysis does not correct for phylogenetic noninde-
pendence, which is the tendency for traits to be similar
between closely related strains solely due to phyloge-
netic history. If not controlled for, traits can be incor-
rectly concluded to be selected by the same ecological
pressures, when in fact they are correlated due to so-
called phylogenetic inertia. Therefore, to control for the
effects of phylogeny, we repeated the analysis using
PICs via the method of Felsenstein. This analysis reveals
that mean persistence at 49 MIC and mean resistance
are still significantly correlated after correcting for phy-
logeny (Fig. 4b; r = 0.731, d.f. = 6, P < 0.05).
To explore the mechanistic basis of variation in per-
sistence, we compared our phenotypic data with the
number of TAs in the genomes of our isolates.
Although type II TAs are known to play a major role in
persister formation, it is unclear to what extent varia-
tion in the copy number of type II TAs between isolates
can explain variation in persistence. Strikingly, the
number of predicted TAs in a genome significantly cor-
relates with the mean level of persistence (Fig. 5a, b;
phylogenetically independent correlation: r = 0.793,
d.f. = 6, P < 0.05). In other words, the greater the
number of TAs in a genome the higher the mean level
of persistence. In contrast, there is no significant rela-
tionship between the number of TAs and antimicrobial
resistance (Fig. 6a, b; phylogenetically independent cor-
relation: r = 0.478, d.f. = 6, P = 0.231). In other words,
TAs do not appear to contribute to antimicrobial resis-
tance. Therefore, although persistence and resistance
are phenotypically correlated, they appear to be mecha-
nistically unrelated.
One feature which may underlie this pattern is varia-
tion in genome size, as the isolates used in our system
vary by over 2.5 MB in genome size (€Ozen & Ussery,
2012). It has been previously demonstrated that the
number of TAs roughly correlates with genome size
(Makarova et al., 2009). We therefore reanalysed the
relationship between persistence and resistance using
partial correlations to control for the effect of genome
size. Partial correlations are a technique whereby the
correlation between two variables is tested for whether
it could be caused by both variables independently cor-
relating with a third variable. This analysis reveals that
the correlation between persistence and resistance is no
stronger than would be expected if both are unrelated
to each other but both independently correlated with
genome size (phylogenetically corrected partial correla-
tion: r = 0.223, d.f. = 5, P = 0.630). In contrast, the
relationship between persistence and the number of
TAs is stronger than expected from both being simply
Table 1 Results of a fully factorial general mixed model on the
mean level of persistence across different strains of Pseudomonas for
the antibiotics rifampicin and ciprofloxacin.





Strain 7,239 98.14 > 0.001 46.32
Dose 2,239 75.95 > 0.001 10.24
Antibiotic 1,239 00.94 0.293 00.06
Strain 9 dose 14,239 01.96 > 0.01 01.85
Strain 9 antibiotic 7,239 50.29 > 0.001 23.74
Antibiotic 9 dose 2,239 21.13 > 0.001 02.85
Antibiotic 9
strain 9 dose
14,239 01.10 0.208 01.04
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properties of genome size (phylogenetically corrected
partial correlation: r = 0.894, d.f. = 5, P < 0.01). This
suggests that the positive correlation between resistance
and persistence simply reflects the fact that strains of
Pseudomonas with large genomes have independently
evolved high levels of both persistence and resistance.
Discussion
In this manuscript, we report a phenotypic association
between antibiotic susceptibility and bacterial persis-
tence. This suggests that at a broad evolutionary scale,
they represent complimentary adaptations to stressful
ecological niches. However, as resistance and persistence
are known to have different mechanistic causes, we
unsurprisingly find that the relationship appears to not
be causal. Specifically, we present evidence that the level
of persistence of a bacterial strain can be predicted from
the number of type II TAs in its genome. Admittedly, this
is only from a sample of eight isolates, so requires addi-
tional genomewide association studies (GWAS) to be
fully verified. However, with the increasing volumes of
genomic data available for pathogenic bacteria, there is
increasing interest in predicting bacterial phenotypes
from sequence data. So-called GWAS have had some
success predicting virulence and antimicrobial resistance
(reviewed in Read & Massey, 2014). From our relatively
small study, it appears persistence may be predicted from
sequence data. This is somewhat surprising when one
considers how only a few years ago the molecular basis
of persistence was still obscure. Although many genes
were known to influence persister formation, they
seemed so disparate and general that predicting persis-
tence solely from genomic data would have appeared
impossible. However, given the emerging role of TAs in
persistence phenotypes, it seems tentatively more
promising to relate persistence to sequence data. A
caveat to this argument is that persisters are thought to
be a universal property of bacteria (Lewis, 2010a, b),
whereas TAs are not (Pandey & Gerdes, 2005; Makarova
et al., 2009). Aside from whether improved knowledge
of TAs will reveal their presence in these genomes, the
Fig. 4 (a) mean resistance and mean
persistence correlate across different
strains of Pseudomonas. Each point
represents a different strain. (b)
Resistance and persistence still correlate
after correcting for phylogeny. Each
point represents a different
phylogenetic independent contrast (PIC,
numbered as in Fig. 1).
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predictive power of TAs is limited to strains where TAs
are a major mechanism of persister formation.
Across a diverse range of isolates, we find strain to be
the best predictor of persistence. Although persistence
did significantly differ between antibiotics, this effect
was much smaller than the effect of strain. It has been
previously demonstrated that persistence varies
between genotypes and antibiotics (Stewart & Rozen,
2012; Hofsteenge et al., 2013); however, neither previ-
ous work analysed the effect of strain and antibiotic in
the same statistical test, which would allow the parti-
tioning of variance between the two factors. Although
both papers do show that persistence does not linearly
correlate between different antibiotics, this does not
preclude strain having the greatest predictive power for
persistence. Indeed, in the data presented here
although there is no significant correlation in persis-
tence between the two antibiotics, strain is still found
to explain a greater proportion of variance than antibi-
otic. It is important to understand whether persistence
is mainly due to particular genotypes or particular
antibiotics (or indeed other factors), as it could directly
inform clinical antibiotic choices particular with regard
to chronic or potentially chronic infections. For
example, if certain antibiotics always yield high frac-
tions of persisters, then this antibiotic should be
avoided for the treatment of potentially chronic or
recurrent infections. In contrast, if certain genotypes
always have higher persister fractions, then greater
effort could be made to understand the epidemiology
and spread of these lineages.
The study system used here encompasses the entire
breadth of a genus, and it is therefore questionable
whether our findings can be applied at smaller evolu-
tionary scales. At a within-species scale, there is still con-
siderable variation in both antibiotic susceptibility and
persistence (Stewart & Rozen, 2012; Hofsteenge et al.,
2013), making a correlation between resistance and per-
sistence at least possible. Previous work has generally
focussed on strains within species with the same level of
resistance, resulting in a lack of empirical insight on this
topic. There is still considerable variation in genome size
within a bacterial species (for example Bergthorsson &
Ochman, 1998; Thompson et al., 2005; Loper et al.,
2012), although admittedly not as much variation as
across a genus. However, if similar patterns of genomic
content are observed in other taxa as in the Pseudomonas
genus, then a correlation between persistence and
Fig. 5 (a) the number of type II toxin–
antitoxin (TAs) pairs predicts the mean
level of persistence across strains. Each
point represents a separate strain. (b)
The number of TAs still significantly
correlates with persistence after
correcting for phylogeny. Each point
represents a different phylogenetic
independent contrast (PIC, numbered
as in Fig. 1).
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resistance is quite likely, if perhaps weaker than found
here. It is also interesting to speculate whether the num-
ber of TAs will still be predictive of persistence at a smal-
ler phylogenetic scale. Although there is still
considerable variation in persistence within a species
(Stewart & Rozen, 2012; Hofsteenge et al., 2013), it is still
unclear whether there is also variation in TAs per gen-
ome at this scale. However, variation in TAs is not the
only source of variation in persistence. Although TAs
have a key role in persister formation, many other factors
can also influence the number of persisters found within
a population (Lewis, 2007; Allison et al., 2011; Balaban,
2011; Balaban et al., 2013). Variation in persistence
within a species could be a combination of variation of
TA number, as well as other factors such as the precise
identity of the TAs and also these other cellular systems
which influence persister formation.
We find that isolates with greater genome sizes possess
higher persistence but also higher resistance. If high
levels of both persistence and resistance are found in the
same isolate, it raises the question of what if anything
limits the evolution of these traits. Crucially, there is
growing evidence of trade-offs associated with both per-
sistence and resistance. Although the presence of costs
from high-level antibiotic resistance is well established
(Melnyk et al., 2015; Vogwill & MacLean, 2015), there is
also emerging evidence that higher proportions of persis-
ters are also more costly in terms of growth rate and
competitive ability (Stewart & Rozen, 2012; Stepanyan
et al., 2015). However, if both traits are costly, and both
traits are adaptation to similar selection pressures, it
seems surprising that there is not some sort of trade-off
or inverse relationship between the two. Therefore, per-
sistence and resistance are perhaps best viewed as adap-
tations to different properties of the same selection
pressure, resulting in the traits being linked but not nec-
essarily driven by the exact same properties of an envi-
ronment of niche. Or in other words, in an environment
which does not require a high level of antibiotic resis-
tance, it also does not require a high level of persistence,
but not for precisely the same reason.
In addition to the variation between strains, we
found a significant effect of antibiotic dose and signifi-
cant interactions with antibiotic identity on persistence.
Finding that persistence is a highly variable phenotype
is consistent with previous work from a range of
Fig. 6 (a) the number of type II toxin–
antitoxin (TAs) pairs has no significant
relationship with the mean level of
resistance across strains. Each point
represents a separate strain. (b) The
number of TAs still has no significant
relationship with resistance after
correcting for phylogeny. Each point
represents a different phylogenetic
independent contrast (PIC, numbered
as in Fig. 1).
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systems and illustrates that persister cells do not repre-
sent a homogenous phenotype (Allison et al., 2011; Fas-
ani & Savageau, 2013). Instead, the ‘persistence’
phenotype is actually a diverse composite of many dif-
ferent cellular mechanisms, each of which subtly differs
in how it affects cellular growth and survival, with
some mechanisms resulting in high recalcitrance to
some stresses but less to others. Underlying this is the
diversity of TAs within most bacterial genomes, as well
as the complex up-stream regulation of TAs. For exam-
ple, if a genome contains ten TAs, then it has poten-
tially ten distinct mechanisms of persister formation, or
more if the differing TAs can work in combinations.
Although the molecular basis of most TAs is still
unclear, known mechanisms include inhibition of DNA
gyrase, degradation of mRNA or inhibition of transla-
tion (reviewed in Gerdes et al., 2005). These differing
mechanisms may represent physiological states which
are tolerant of different types of cellular stress. Addi-
tionally, whether these separate routes to persistence
represent alternative or synergistic approaches to cellu-
lar plasticity remains unclear. Therefore, having multi-
ple TAs may permit differing levels of persistence
depending on how many TAs are simultaneously
active, as well as their precise molecular mechanism.
Our study system contains isolates predominately
drawn from environmental samples, as opposed to clini-
cal samples, although P. aeruginosa PAO1 is a clinical
specimen from 1955. Therefore, the selection pressures
shaping this system are likely to be low-level selection of
resistance and tolerance from naturally produced antibi-
otics and other toxins. Clinical systems will in general
exert far greater selection pressures from antibiotic
because of the higher concentrations of antibiotics
required to treat infections. Furthermore, samples from
chronic infections are likely to have been exposed to
even greater selection for both resistance and persis-
tence. However, whether within each of these groups
persistence and resistance will also be correlated remains
to be tested. Perhaps when these traits start to get extre-
mely high, trade-offs start to become more important.
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